GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Inspira Technologies Oxy BHN Ltd (NAS:IINN) » Definitions » Beta

Inspira Technologies Oxy BHN (Inspira Technologies Oxy BHN) Beta : N/A (As of May. 12, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Inspira Technologies Oxy BHN Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-05-12), Inspira Technologies Oxy BHN's Beta is Not available.


Inspira Technologies Oxy BHN Beta Historical Data

The historical data trend for Inspira Technologies Oxy BHN's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inspira Technologies Oxy BHN Beta Chart

Inspira Technologies Oxy BHN Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beta
Get a 7-Day Free Trial - - - - -

Inspira Technologies Oxy BHN Quarterly Data
Jun19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Inspira Technologies Oxy BHN's Beta

For the Medical Devices subindustry, Inspira Technologies Oxy BHN's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inspira Technologies Oxy BHN's Beta Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Inspira Technologies Oxy BHN's Beta distribution charts can be found below:

* The bar in red indicates where Inspira Technologies Oxy BHN's Beta falls into.



Inspira Technologies Oxy BHN Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


Inspira Technologies Oxy BHN  (NAS:IINN) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Inspira Technologies Oxy BHN Beta Related Terms

Thank you for viewing the detailed overview of Inspira Technologies Oxy BHN's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


Inspira Technologies Oxy BHN (Inspira Technologies Oxy BHN) Business Description

Traded in Other Exchanges
N/A
Address
2 Ha-Tidhar Street, Ra'anana, ISR, 4366504
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.